Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
12.1M
-
Shares change
-
-747K
-
Total reported value, excl. options
-
$15.7M
-
Value change
-
-$936K
-
Number of buys
-
7
-
Number of sells
-
-14
-
Price
-
$1.30
Significant Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q2 2023
37 filings reported holding VINC - Vincerx Pharma, Inc. - Common Stock as of Q2 2023.
Vincerx Pharma, Inc. - Common Stock (VINC) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.1M shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (2.06M shares), SAGE RHINO CAPITAL LLC (1.69M shares), Affinity Asset Advisors, LLC (1.49M shares), Long Focus Capital Management, LLC (1.1M shares), Rock Springs Capital Management LP (892K shares), CITADEL ADVISORS LLC (661K shares), Schonfeld Strategic Advisors LLC (602K shares), VANGUARD GROUP INC (520K shares), ExodusPoint Capital Management, LP (426K shares), and KINGDON CAPITAL MANAGEMENT, L.L.C. (385K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.